iTeos Therapeutics, Inc. (ITOS) has an overall financial health rating of B- with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2025-08-28.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-08-28 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-08-27 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-08-26 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-08-25 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-08-22 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-08-21 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-08-20 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-08-19 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-08-18 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-08-15 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-08-14 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2025-08-13 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
